The ubiquitin-proteasome system and endocytosis - PubMed (original) (raw)

Review

. 1999 May:112 ( Pt 10):1417-23.

doi: 10.1242/jcs.112.10.1417.

Affiliations

• PMID: 10212136
• DOI: 10.1242/jcs.112.10.1417

Review

The ubiquitin-proteasome system and endocytosis

G J Strous et al. J Cell Sci. 1999 May.

Abstract

Internalization of membrane proteins has been studied for more than three decades without solving all the underlying mechanisms. Our knowledge of clathrin-mediated endocytosis is certainly sufficient to understand the basic principles. However, more detailed insight is required to recognize why different proteins enter clathrin-coated pits with different rates and affinities. In addition to clathrin coat components, at least two adaptor systems and even more accessory proteins have been described to preselect membrane proteins before they can enter cells. Recent experimental data have identified the ubiquitin-proteasome system as a regulatory system for endocytosis. This system is well-known for its basic regulatory function in protein degradation, and controls a magnitude of key events. The ubiquitin-proteasome system is now identified as a regulator of the endocytosis of selected membrane proteins. In this review, we will discuss the complexity and implications of this mechanism for receptor-mediated endocytosis.

PubMed Disclaimer

Similar articles

• Dimerization, ubiquitylation and endocytosis go together in growth hormone receptor function.
  Strous GJ, Gent J. Strous GJ, et al. FEBS Lett. 2002 Oct 2;529(1):102-9. doi: 10.1016/s0014-5793(02)03187-3. FEBS Lett. 2002. PMID: 12354620 Review.
• The signal transduction of the growth hormone receptor is regulated by the ubiquitin/proteasome system and continues after endocytosis.
  Alves dos Santos CM, van Kerkhof P, Strous GJ. Alves dos Santos CM, et al. J Biol Chem. 2001 Apr 6;276(14):10839-46. doi: 10.1074/jbc.M003635200. Epub 2001 Jan 10. J Biol Chem. 2001. PMID: 11152671
• The ubiquitin-dependent endocytosis motif is required for efficient incorporation of growth hormone receptor in clathrin-coated pits, but not clathrin-coated lattices.
  Sachse M, van Kerkhof P, Strous GJ, Klumperman J. Sachse M, et al. J Cell Sci. 2001 Nov;114(Pt 21):3943-52. doi: 10.1242/jcs.114.21.3943. J Cell Sci. 2001. PMID: 11719561
• Cbl-dependent ubiquitination is required for progression of EGF receptors into clathrin-coated pits.
  Stang E, Blystad FD, Kazazic M, Bertelsen V, Brodahl T, Raiborg C, Stenmark H, Madshus IH. Stang E, et al. Mol Biol Cell. 2004 Aug;15(8):3591-604. doi: 10.1091/mbc.e04-01-0041. Epub 2004 Jun 11. Mol Biol Cell. 2004. PMID: 15194809 Free PMC article.
• Endocytic accessory factors and regulation of clathrin-mediated endocytosis.
  Merrifield CJ, Kaksonen M. Merrifield CJ, et al. Cold Spring Harb Perspect Biol. 2014 Oct 3;6(11):a016733. doi: 10.1101/cshperspect.a016733. Cold Spring Harb Perspect Biol. 2014. PMID: 25280766 Free PMC article. Review.

Cited by

• In vivo Structure/Function analysis of the Drosophila fat facets deubiquitinating enzyme gene.
  Chen X, Fischer JA. Chen X, et al. Genetics. 2000 Dec;156(4):1829-36. doi: 10.1093/genetics/156.4.1829. Genetics. 2000. PMID: 11102377 Free PMC article.
• COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments.
  Benharouga M, Haardt M, Kartner N, Lukacs GL. Benharouga M, et al. J Cell Biol. 2001 May 28;153(5):957-70. doi: 10.1083/jcb.153.5.957. J Cell Biol. 2001. PMID: 11381082 Free PMC article.
• Incidence and risk of cardiac toxicities in patients with relapsed and refractory multiple myeloma treated with carfilzomib.
  Zhao F, Yang B, Wang J, Zhang R, Liu J, Yin F, Xu W, He C. Zhao F, et al. Drug Des Devel Ther. 2018 May 30;12:1525-1531. doi: 10.2147/DDDT.S159818. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29881259 Free PMC article.
• Morphogenesis of Bullet-Shaped Rabies Virus Particles Regulated by TSG101.
  Itakura Y, Tabata K, Saito T, Intaruck K, Kawaguchi N, Kishimoto M, Torii S, Kobayashi S, Ito N, Harada M, Inoue S, Maeda K, Takada A, Hall WW, Orba Y, Sawa H, Sasaki M. Itakura Y, et al. J Virol. 2023 May 31;97(5):e0043823. doi: 10.1128/jvi.00438-23. Epub 2023 Apr 12. J Virol. 2023. PMID: 37042780 Free PMC article.
• Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.
  Soave CL, Guerin T, Liu J, Dou QP. Soave CL, et al. Cancer Metastasis Rev. 2017 Dec;36(4):717-736. doi: 10.1007/s10555-017-9705-x. Cancer Metastasis Rev. 2017. PMID: 29047025 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database